Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JETBLUE AIRWAYS CORP files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
6,632
7,015
7,658
8,094
2,957
6,037
9,158
9,615
9,279
9,062
Selling and marketing
263
271
294
290
110
183
289
316
328
305
Operating income
1,260
973
266
800
-1,714
-80
-298
-230
-684
-368
Interest expense
6
166
210
365
588
Interest income
21
70
111
127
Other non-operating income
-96
-55
-47
-32
-179
-183
-139
-104
-213
-406
Pre-tax income
1,164
918
219
768
-1,893
-263
-437
-334
-897
-774
Income tax
437
-222
30
199
-539
-81
-75
-24
-102
-172
Net income
727
1,140
189
569
-1,354
-182
-362
-310
-795
-602
EBITDA
1,653
1,397
735
1,325
-1,179
460
287
391
-29
320
EPS, basic
2.23
3.47
0.60
1.92
-4.88
-0.57
-1.12
-0.93
-2.30
-1.66
EPS, diluted
2.13
3.45
0.60
1.91
-4.88
-0.57
-1.12
-0.93
-2.30
-1.66
Shares, basic (weighted)
327
329
313
297
278
318
324
333
346
362
Shares, diluted (weighted)
342
330
315
298
278
318
324
333
346
362
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
433
303
474
959
1,918
2,018
1,042
1,166
1,921
1,946
Short-term investments
538
390
413
369
1,135
824
350
401
1,689
213
Receivables
172
245
211
231
98
207
317
336
348
372
Inventory
47
55
78
81
71
74
87
109
158
193
Other current assets
260
213
212
146
123
122
120
148
142
414
Total current assets
1,403
1,206
1,388
1,786
3,345
3,245
1,916
2,160
4,258
3,238
Property, plant and equipment
7,271
8,049
7,983
8,614
8,399
8,814
9,147
9,675
10,656
11,191
Lease right-of-use assets
1,056
912
804
729
660
593
550
868
Intangible assets
241
261
299
298
349
399
415
Long-term investments
90
2
3
3
2
39
172
153
174
211
Other non-current assets
497
468
470
303
544
457
706
762
415
291
Total assets
9,323
9,781
10,959
11,918
13,406
13,642
13,045
13,853
16,841
16,570
Accounts payable
242
378
437
401
365
499
532
641
619
655
Accrued liabilities
342
313
313
376
409
480
498
591
663
680
Deferred revenue
1,119
1,122
1,618
1,581
1,463
1,572
1,669
Short-term debt
189
196
309
344
450
355
554
307
392
769
Total current liabilities
2,214
2,146
2,525
2,663
2,674
3,417
3,748
3,628
3,881
4,402
Long-term debt
1,195
1,003
1,361
1,990
4,413
3,651
3,093
4,409
8,147
7,729
Lease liabilities
798
690
752
690
639
547
510
839
Other non-current liabilities
90
75
31
44
78
552
494
449
376
329
Total liabilities
5,390
4,976
6,274
7,119
9,455
9,793
9,482
10,516
14,200
14,450
Total debt
1,244
1,075
1,563
2,245
4,800
4,003
3,645
4,716
8,539
8,498
Paid-in capital
2,050
2,127
2,203
2,253
2,959
3,047
3,129
3,221
3,320
3,412
Retained earnings
2,446
3,491
3,753
4,322
2,968
2,786
2,424
2,114
1,319
717
Treasury stock
-500
-890
-1,272
-1,782
-1,981
-1,989
-1,995
-1,999
-2,005
-2,013
Other comprehensive income
13
0
-3
2
0
0
0
-4
2
-1
Shareholders' equity
4,013
4,732
4,685
4,799
3,951
3,849
3,563
3,337
2,641
2,120
Total equity
3,933
4,805
4,685
4,799
3,951
3,849
3,563
3,337
2,641
2,120
Total liabilities and equity
9,323
9,781
10,959
11,918
13,406
13,642
13,045
13,853
16,841
16,570
Shares outstanding
337
321
306
282
316
320
327
339
353
370
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
727
1,140
189
569
-1,354
-182
-362
-310
-795
-602
Depreciation and amortization
393
424
469
525
535
540
585
621
655
688
Stock-based compensation
23
29
28
31
28
28
30
39
39
40
Deferred income tax
251
-309
90
139
-329
-88
-73
-27
-110
-183
Change in receivables
-21
-52
46
-3
144
-46
-111
-3
4
-22
Cash from operations
1,632
1,379
1,200
1,449
-683
1,642
379
400
144
-94
Capital expenditures
-850
-1,074
-908
-932
-715
-907
-767
-1,128
-1,478
-1,078
Acquisitions
0
0
-297
-131
-22
0
Purchases of investments
-979
-1,000
-1,962
-1,577
-473
-474
-1,778
-480
Sales and maturities of investments
875
880
1,174
1,910
934
489
487
2,041
Cash from investing
-1,046
-979
-1,157
-1,129
-1,349
-704
-908
-1,378
-3,080
658
Debt issued
0
0
687
981
2,541
1,010
0
78
3,793
0
Stock issued
45
48
48
51
619
46
52
53
60
52
Share buybacks
-120
-380
-375
-535
-160
Cash from financing
-472
-536
131
165
2,983
-830
-360
1,107
3,767
-417
Net change in cash
115
-130
174
485
951
108
-889
129
831
147
Free cash flow
782
305
292
517
-1,398
735
-388
-728
-1,334
-1,172
Interest paid
78
60
59
62
139
180
124
80
230
427
Income taxes paid
173
139
11
-52
5
-3
45
-49
2
-2
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.40 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
-5.9%
Operating income / revenue.
EBITDA margin
1.5%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-10.7%
Pre-tax income / revenue.
Net margin
-9.3%
Net income / revenue.
FCF margin
-11.4%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-1.3%
Cash from operations / revenue.
Return on equity (ROE)
-55.8%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-5.4%
Net income / average total assets.
Return on invested capital (ROIC)
-5.3%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
0.4%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
10.0%
Capital expenditures / revenue.
D&A / revenue
7.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-2.3%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-0.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
25.1%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y
3.7%
Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y
-165.3%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-19.7%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-15.9%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-11.7%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-1.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
8.3%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
4.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
4.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
3.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
5.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.70x
Current assets / current liabilities.
Quick ratio
0.54x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.45x
(Cash + short-term investments) / current liabilities.
Debt / equity
5.34x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
51.8%
Total debt / total assets.
Liabilities / assets
90.3%
Total liabilities / total assets.
Net debt
$6.46B
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
44.2x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$25.28
Revenue / diluted weighted shares.
FCF per share
-$2.88
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.34
Cash from operations / diluted weighted shares.
Book value per share
$4.21
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.17x
Market cap / revenue.
P/B
1.05x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
1.32x
Market cap / tangible book value, when positive.
EV/Sales
0.85x
Enterprise value / revenue.
EV/EBITDA
55.6x
Enterprise value / EBITDA, when both are positive.
FCF yield
-65.1%
Free cash flow / market cap.
Earnings yield
-53.4%
Net income / market cap (the inverse of P/E).
What was JETBLUE AIRWAYS CORP's revenue in fiscal 2025?
JETBLUE AIRWAYS CORP reported revenue of $9.06B for fiscal 2025, 2.3% lower than the year before.
Was JETBLUE AIRWAYS CORP profitable in fiscal 2025?
No. It reported a net loss of $602.0M.
How much free cash flow did JETBLUE AIRWAYS CORP generate in fiscal 2025?
Cash from operations of $94.0M minus capital expenditures of $1.08B left free cash flow of -$1.17B.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.